Characteristics of children included in the study, that is, all births in Ontario occurring 1 January 1993 to 31 December 2016, stratified by palivizumab eligibility group
Characteristic | Ineligible | Possibly eligible | Eligible | |||
N | % | N | % | N | % | |
n=2 837 145 | n=1 43 913 | n=34 301 | ||||
Birth characteristics | ||||||
Birth year | ||||||
1993–1996 | 462 235 | 16.29 | 22 377 | 15.55 | 7015 | 20.45 |
1997–2000 | 443 707 | 15.64 | 23 284 | 16.18 | 6732 | 19.63 |
2001–2004 | 464 534 | 16.37 | 23 595 | 16.40 | 5670 | 16.53 |
2005–2008 | 494 542 | 17.43 | 24 291 | 16.88 | 5197 | 15.15 |
2009–2012 | 487 847 | 17.19 | 24 607 | 17.10 | 4939 | 14.40 |
2013–2016 | 484 280 | 17.07 | 25 759 | 17.90 | 4748 | 13.84 |
High risk birth month (November–January) | 655 754 | 23.11 | 42 315 | 29.40 | 9832 | 28.66 |
Sex (female) | 1 387 750 | 48.91 | 65 046 | 45.20 | 15 317 | 44.65 |
Multiple birth | 53 151 | 1.87 | 28 868 | 20.06 | 7473 | 21.79 |
Estimated wGA | ||||||
<28 wGA (extremely preterm) | 1753 | 0.06 | 261 | 0.18 | 11 338 | 33.05 |
28–32 wGA (very preterm) | 2973 | 0.10 | 377 | 0.26 | 15 408 | 44.92 |
33–36 wGA (preterm) | 30 620 | 1.08 | 131 800 | 91.58 | 2095 | 6.11 |
37+ wGA (term) | 2 763 110 | 97.39 | 10 935 | 7.60 | 5309 | 15.48 |
Missing | 38 689 | 1.36 | 540 | 0.38 | 151 | 0.44 |
Weight group | ||||||
<1500 g | 4337 | 0.15 | 2852 | 1.98 | 22 672 | 66.10 |
1500–1999 g | 6562 | 0.23 | 25 261 | 17.55 | 4360 | 12.71 |
2000–2499 g | 70 582 | 2.49 | 45 815 | 31.84 | 1251 | 3.65 |
2500–2999 g | 423 850 | 14.94 | 42 265 | 29.37 | 1823 | 5.31 |
3000–3499 g | 1 069 534 | 37.70 | 20 878 | 14.51 | 2201 | 6.42 |
3500–3999 g | 902 861 | 31.82 | 5147 | 3.58 | 1390 | 4.05 |
4000–4499 g | 301 482 | 10.63 | 1253 | 0.87 | 470 | 1.37 |
4500 g + | 57 937 | 2.04 | 442 | 0.31 | 134 | 0.39 |
Mean weight, g (SD) | 3438.42 | 503.43 | 2495.50 | 579.44 | 1512.84 | 958.70 |
Congenital diseases† | ||||||
Any major congenital anomaly | 49 968 | 1.76 | 19 550 | 13.58 | 13 137 | 38.30 |
CHD | 0 | – | 13 453 | 9.35 | 11 239 | 32.77 |
Hemodynamically significant CHD | 0 | – | 0 | – | 6596 | 19.23 |
Other CHD | 0 | – | 13 453 | 9.35 | 4643 | 13.54 |
Major congenital airway anomaly | 0 | – | 1980 | 1.38 | 349 | 1.02 |
Other clinical diagnoses† | ||||||
Bronchopulmonary dysplasia/ chronic lung disease | 0 | – | 0 | – | 4311 | 12.57 |
Trisomy 21 | 0 | – | 1044 | 0.73 | 173 | 0.50 |
Sociodemographic characteristics * | ||||||
Mother’s immigration status | ||||||
Canadian born | 2 207 476 | 77.81 | 112 047 | 77.86 | 26 804 | 78.14 |
Long-term resident, 5+ years | 332 367 | 11.71 | 17 810 | 12.38 | 4176 | 12.17 |
Short-term resident,<5 years | 293 622 | 10.35 | 13 837 | 9.61 | 3261 | 9.51 |
Refugee | 3680 | 0.13 | 219 | 0.15 | 60 | 0.17 |
Maternal age | ||||||
<18 years | 64 765 | 2.28 | 3743 | 2.60 | 1081 | 3.15 |
19–24 | 428 232 | 15.09 | 21 141 | 14.69 | 5385 | 15.70 |
25–29 | 828 752 | 29.21 | 38 524 | 26.77 | 9300 | 27.11 |
30–34 | 969 408 | 34.17 | 47 281 | 32.85 | 10 761 | 31.37 |
35–39 | 458 174 | 16.15 | 26 592 | 18.48 | 6192 | 18.05 |
40+ | 87 758 | 3.09 | 6626 | 4.60 | 1579 | 4.60 |
Mean maternal age (SD) | 29.73 | 5.44 | 30.13 | 5.79 | 29.88 | 5.93 |
Neighbourhood income quintile | ||||||
1 (lowest 20% income) | 626 463 | 22.08 | 33 814 | 23.50 | 442 | 1.29 |
2 | 567 822 | 20.01 | 29 532 | 20.52 | 8575 | 25.00 |
3 | 568 979 | 20.05 | 28 662 | 19.92 | 7193 | 20.97 |
4 | 581 546 | 20.50 | 28 524 | 19.82 | 6603 | 19.25 |
5 (highest 20% income) | 467 644 | 16.48 | 22 175 | 15.41 | 6530 | 19.04 |
Missing | 24 691 | 0.87 | 1206 | 0.84 | 4958 | 14.45 |
Residence at time of birth | ||||||
Urban | 2 518 452 | 88.77 | 129 573 | 90.04 | 30 057 | 87.63 |
Rural | 307 202 | 10.83 | 13 763 | 9.56 | 4047 | 11.80 |
Missing | 11 491 | 0.41 | 577 | 0.40 | 197 | 0.57 |
Geographically isolated residence | 23 391 | 0.82 | 97 | 0.07 | 1041 | 3.03 |
Statistically significant difference between eligibility groups noted across all characteristics; p<0.0001.
*Determined at the time of birth.
†Diagnosed before second birthday.
BPD, bronchopulmonary dysplasia; CHD, congenital heart disease; CLD, chronic lung disease; wGA, weeks gestational age.